Antiretroviral therapy, a breakthrough treatment for HIV infection, suppresses the levels of circulating HIV viral particles in the blood. When it works, cancer rates drop, according to a new study. Still, even when the therapy is successful, HIV-positive individuals retain elevated rates of cancer.
A "molecular car wash" may help dermatologists accurately and more quickly identify and remove tiny skin cancers caused by sun damage. The technique also pinpoints subtle molecular differences associated with the cancers that may one day guide treatment.
New Stanford Medicine research found that a compound called d-limonene has the potential to help head and neck cancer patients who suffer from dry mouth.
With half of all cases of Alzheimer's disease and related dementias going undiagnosed, researchers develop app to help in early screening
When Stanford's James Spudich was diagnosed with lung cancer, one of his first thoughts was of his colleague, lung development expert Mark Krasnow. Within hours a group of Stanford scientists had launched an astoundingly comprehensive study of healthy and diseased human lung tissue from one of their own.
Scientists at Stanford have created a new PET scan-compatible tracing agent that tracks immune cells poised to attack cancer, offering a new way to predict the success of certain therapies.
Women with breast cancer are increasingly receiving multigene genetic testing rather than just screening for the BRCA mutations, new research suggests.
When Ron Gross needed a bone marrow transplant, an international donor stepped in, providing a gift that led to a lifelong friendship.
Cancer survivor Ali Zidel Meyers reflects on joining a cancer writing group and how it helped her and others through their experience.
The U.S. Preventive Services Task Force is now recommending that men aged 55 to 69 should talk with their doctors about prostate-specific antigen screening.
Stanford researchers solve a long-standing mystery as to how mutations in a neighboring stretch of DNA can increase the expression of a cancer-associated gene called Myc. The finding highlights a potential new class of targets to block cancer cell growth.
Stanford Medicine doctors have partnered with colleagues in Nigeria to improve cancer care with the goal of reducing inequities.
Scientists have made an important step forward in treating a deadly childhood brain tumor, using T cells engineered to target a surface sugar found on the cancer cells.
Robert Negrin outlined the history of Stanford's bone marrow transplantation program and touched on research and other developments in the field over the past 30 years.
When associated with tumors, immune cells known as macrophages can be both good and bad: they can help cancer spread and curb its growth.
Stanford researchers develop a new way to track the growth of diverse tumor types, using gene editing and DNA barcoding.